147
Participants
Start Date
August 31, 2008
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
AA4500
2 single injections of study drug per each treatment series up to three treatment series total in study. Each treatment series was separated by 6 weeks.
Placebo
2 single injections of study drug per each treatment series up to three treatment series total in study. Each treatment series is separated by 6 weeks.
University Urology Associates, New York
Maimonides Medical Center Divison of Urology, Brooklyn
Urology of Virginia (a division of Sentara Medical Group), Norfolk
South Florida Medical Research, Aventura
Tristate Urologic Services, Cincinnati
Northeast Indiana Research, LLC, Fort Wayne
Metropolitan Urology, PSC, Jeffersonville
Urology Specialists, SC, Chicago
Baylor College of Medicine, Scott Department of Urology, Houston
Urology Associates Medical Group, Burbank
Urology Specialists Connecticut Clinical Research Center, LLC, Middlebury
The Urology Center, PC, New Haven
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY